Trevi TherapeuticsTRVI
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 77 institutions reported holding Trevi Therapeutics Inc. (TRVI) in their 13F filings, down 3 from Q1 2024. 4 opened new positions and 9 sold out. The largest holders were NEA Management Company, LLC ($33.9M), Frazier Life Sciences Management, L.P. ($22.0M) and Rubric Capital Management LP ($15.0M). 2 famous investors held it, including Andreas Halvorsen (0.1% of Viking Global Investors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Trevi Therapeutics Inc.
- CUSIP
- 89532M101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $5.3M |
| Exits | 9 | $502K |
All 13F filers, Q1 2024 → Q2 2024: 5,288,056 shares bought and 995,587 shares sold, net +4,292,469 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 77 holders
| NEA Management Company, LLC | 2.55% | No change | 11,370,376 | $33.9M |
| Frazier Life Sciences Management, L.P. | 1.03% | No change | 7,381,090 | $22.0M |
| Rubric Capital Management LP | 0.40% | Reduce -9.7% | 5,026,931 | $15.0M |
| Viking Global Investors | 0.05% | No change | 4,400,000 | $13.1M |
| Venrock Adviser, LLC | 0.65% | Reduce 0.0% | 3,422,637 | $10.2M |
| BlackRock Inc. | 0.00% | Add +32.0% | 3,135,115 | $9.3M |
| Logos Global Management LP | 0.96% | Add +27.3% | 2,800,000 | $8.3M |
| Opaleye Management Inc. | 1.83% | No change | 2,645,000 | $7.9M |
| Vanguard Group Inc. | 0.00% | Add +5.8% | 2,437,451 | $7.3M |
| MPM Bioimpact LLC | 0.70% | Add +12.6% | 1,510,174 | $4.5M |
| Ally Bridge Group (NY) LLC | 2.62% | New | 1,474,926 | $4.4M |
| Rosalind Advisors, Inc. | 3.28% | Add +50.3% | 1,391,577 | $4.1M |
| MAI Capital Management | 0.04% | Add +16.5% | 1,318,496 | $3.9M |
| Geode Capital Management, LLC | 0.00% | Add +27.7% | 1,146,748 | $3.4M |
| State Street Corp. | 0.00% | Add +12.7% | 899,861 | $2.7M |
| Silverarc Capital Management, LLC | 0.62% | No change | 844,235 | $2.5M |
| Landscape Capital Management, L.L.C. | 0.15% | Reduce -18.2% | 605,442 | $1.8M |
| Checkpoint Capital L.P. | 0.90% | Reduce -1.2% | 500,089 | $1.5M |
| Tejara Capital Ltd | 0.44% | Add +983.2% | 405,988 | $1.2M |
| Northern Trust Corp. | 0.00% | Reduce -2.0% | 321,102 | $957K |
| Acuta Capital Partners, LLC | 0.65% | New | 260,000 | $775K |
| Propel Bio Management, LLC | 0.50% | No change | 260,000 | $775K |
| Simplify Asset Management Inc. | 0.05% | No change | 200,000 | $596K |
| Bridgeway Capital Management, LLC | 0.01% | Add +92.3% | 185,481 | $553K |
| Bank of New York Mellon Corp | 0.00% | Add +38.8% | 178,511 | $532K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +40.1% | 150,918 | $450K |
| J. Goldman & Co LP | 0.02% | Add +8.0% | 148,917 | $444K |
| Nuveen Asset Management, LLC | 0.00% | Add +28.7% | 96,350 | $287K |
| Morgan Stanley | 0.00% | Add +30.4% | 88,981 | $265K |
| Shay Capital LLC | 0.07% | Reduce -22.2% | 88,462 | $264K |
| PFS Partners, LLC | 0.15% | Reduce -20.2% | 79,000 | $235K |
| Rhumbline Advisers | 0.00% | Add +44.8% | 75,218 | $224K |
| Goldman Sachs Group Inc. | 0.00% | Add +92.8% | 73,193 | $218K |
| Dimensional Fund Advisors LP | 0.00% | Add +217.6% | 72,210 | $215K |
| Jane Street Group, LLC | 0.00% | Add +288.3% | 66,368 | $198K |
| WealthTrust Axiom LLC | 0.06% | No change | 63,500 | $189K |
| Oppenheimer & Co. Inc. | 0.00% | Add +0.7% | 60,819 | $181K |
| American Century Companies Inc. | 0.00% | Add +17.1% | 54,108 | $161K |
| Renaissance Technologies | 0.00% | Reduce -55.6% | 51,900 | $155K |
| Bank of America Corp. | 0.00% | Add +101.5% | 44,284 | $132K |
| Bailard, Inc. | 0.00% | No change | 40,900 | $122K |
| Trust Co. of Toledo NA | 0.02% | No change | 36,502 | $109K |
| LPL Financial LLC | 0.00% | No change | 36,000 | $107K |
| Barclays PLC | 0.00% | Reduce -3.6% | 33,915 | $101K |
| Corebridge Financial, Inc. | 0.00% | — | 31,595 | $94K |
| JPMorgan Chase & Co. | 0.00% | Add +23.1% | 31,350 | $93K |
| United Bank | 0.01% | Add +9.7% | 31,200 | $93K |
| Manufacturers Life Insurance Company, The | 0.00% | Add +87.6% | 24,524 | $73K |
| Wells Fargo & Company | 0.00% | Add +39.4% | 23,478 | $70K |
| Voya Investment Management LLC | 0.00% | Add +69.0% | 22,434 | $67K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | — | 21,151 | $63K |
| HSBC Holdings PLC | 0.00% | New | 19,612 | $61K |
| Invesco Ltd. | 0.00% | Reduce -0.8% | 19,723 | $59K |
| T. Rowe Price Associates Inc. | 0.00% | Add +40.5% | 19,047 | $57K |
| MetLife Investment Management, LLC | 0.00% | Reduce -16.8% | 18,881 | $56K |
| UBS Group AG | 0.00% | Reduce -57.2% | 18,009 | $54K |
| Alliancebernstein L.P. | 0.00% | New | 15,440 | $46K |
| New York State Common Retirement Fund | 0.00% | Add +1.4% | 15,265 | $45K |
| Ameriprise Financial Inc. | 0.00% | Reduce -30.8% | 14,948 | $45K |
| Deutsche Bank AG | 0.00% | Reduce -21.9% | 13,923 | $41K |
| Citigroup Inc. | 0.00% | Add +49.2% | 12,987 | $39K |
| Stifel Financial Corp. | 0.00% | Add +21.8% | 12,303 | $37K |
| Raymond James & Associates | 0.00% | No change | 10,000 | $30K |
| STRS Ohio | 0.00% | No change | 8,200 | $24K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1057.5% | 7,061 | $21K |
| Legal & General Group Plc | 0.00% | Add +64.6% | 6,542 | $19K |
| Royal Bank of Canada | 0.00% | Add +278.8% | 5,542 | $16K |
| BNP Paribas Financial Markets | 0.00% | Reduce -74.9% | 5,166 | $15K |
| California State Teachers Retirement System | 0.00% | Add +0.4% | 4,255 | $13K |
| FMR LLC | 0.00% | Add +1.9% | 3,604 | $11K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 3,438 | $10K |
| Lanark Financial, Inc. | 0.00% | No change | 2,000 | $5K |
| Amalgamated Bank | 0.00% | No change | 1,403 | $4K |
| Federated Hermes, Inc. | 0.00% | No change | 773 | $2K |
| Farther Finance Advisors, LLC | 0.00% | No change | 55 | $159 |
| Nisa Investment Advisors, LLC | 0.00% | No change | 3 | $9 |
| Cwm, LLC | 0.00% | Add +1000.0% | 33 | $0 |
"% of holder's portfolio" is TRVI's weight in each manager's 13F, not the share of Trevi Therapeutics Inc. the manager owns.